Published in Eur J Clin Pharmacol on January 01, 1986
Clinical pharmacokinetics of felodipine. A summary. Drugs (1987) 0.87
Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study. Drugs (1987) 0.87
Felodipine versus Moduretic. A double-blind parallel-group multicentre study. Drugs (1987) 0.84
Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension. Drugs (1987) 0.79
Felodipine ER formulation in the treatment of mild hypertension: efficacy and tolerability vs placebo. Br J Clin Pharmacol (1990) 0.78
Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine. Br J Clin Pharmacol (1987) 0.78
Pharmacokinetics of felodipine after intravenous and chronic oral administration in patients with congestive heart failure. Br J Clin Pharmacol (1989) 0.75
Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets. Br J Clin Pharmacol (1990) 0.75
Pharmacokinetics of felodipine in patients with impaired renal function. Br J Clin Pharmacol (1989) 0.75
Short and long term treatment of essential hypertension with felodipine as monotherapy. Drugs (1987) 0.75
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Smoking and myocardial infarction. Lancet (1975) 3.42
Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59
Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press (1992) 2.49
Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. BMJ (1992) 2.31
Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis (1975) 2.20
The occurrence of Campylobacter jejuni in fresh food and survival under different conditions. J Hyg (Lond) (1981) 1.98
Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain (1992) 1.89
Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA (1988) 1.87
The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J (1986) 1.85
Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension. Eur J Clin Pharmacol (1983) 1.77
Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol (1991) 1.66
Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64
[There is no reason to avoid calcium antagonists in hypertension]. Lakartidningen (1996) 1.62
Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl (1988) 1.55
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ (1994) 1.52
Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris. Cardiology (1998) 1.51
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment. J Hypertens (2000) 1.48
Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic beta2 receptor in a Swedish hypertensive population. J Hum Hypertens (2005) 1.45
Antimicrobial susceptibility of Campylobacter jejuni isolated from humans with diarrhoea and from healthy chickens. J Antimicrob Chemother (1981) 1.42
Psychotropic drug use in pregnancy and perinatal death. Acta Obstet Gynecol Scand (1992) 1.39
Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. Am J Hypertens (1991) 1.39
Prediction of cardiovascular deaths and non-fatal reinfarctions after myocardial infarction. Acta Med Scand (1977) 1.38
Lipoprotein metabolism and renal failure. Am J Kidney Dis (1993) 1.37
Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. Br J Clin Pharmacol (1983) 1.35
Campylobacter upsaliensis, C. sputorum sputorum and C. concisus as common causes of diarrhoea in Swedish children. Scand J Infect Dis (1995) 1.31
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28
Topical anesthesia with lidocaine aerosol in the control of postoperative pain. Anesthesiology (1988) 1.27
Brain natriuretic peptide predicts mortality in the elderly. Heart (1997) 1.27
Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. Acta Physiol Scand (1988) 1.27
Alcoholic intemperance, coronary heart disease and mortality in middle-aged Swedish men. Acta Med Scand (1987) 1.26
A controlled trial of physical training after myocardial infarction. Effects on risk factors, nonfatal reinfarction, and death. Prev Med (1975) 1.26
The cost-effectiveness of a cardiovascular multiple-risk-factor intervention programme in treated hypertensive men. J Intern Med (1995) 1.25
Campylobacter jejuni/coli and enterotoxigenic Escherichia coli (ETEC) in faeces from children and adults in Tanzania. Scand J Infect Dis (1995) 1.23
Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC. Antimicrob Agents Chemother (1998) 1.22
Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res (1995) 1.22
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Adenosine mechanisms in the regulation of breathing in the rat. Eur J Pharmacol (1984) 1.20
Acute diuretic/natriuretic properties of felodipine in man. Drugs (1985) 1.20
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens (2001) 1.19
Water intoxication associated with non-steroidal anti-inflammatory drug therapy. Acta Med Scand (1987) 1.18
Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study. Hypertension (1991) 1.17
Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol (1991) 1.16
STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension. Blood Press (1993) 1.15
Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol (2003) 1.15
Atrial natriuretic peptides predict mortality in the elderly. J Intern Med (1997) 1.14
Short-term effects of felodipine, a new dihydropyridine, in hypertension. Br J Clin Pharmacol (1984) 1.14
Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. J Pharm Pharmacol (1982) 1.14
A postmyocardial infarction clinic in Göteborg, Sweden. A follow-up of MI patients in a specialized out-patient clinic. Acta Med Scand (1975) 1.13
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens (1990) 1.13
Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care. Acta Med Scand Suppl (1985) 1.12
Campylobacter strains in Sweden. Serotyping and correlation to clinical symptoms. Acta Pathol Microbiol Immunol Scand B (1985) 1.10
Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain (1994) 1.09
Non-participants in a general population study of men, with special reference to social and alcoholic problems. Acta Med Scand (1987) 1.09
Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension. Drugs (1985) 1.08
Antihypertensive effects of felodipine compared with placebo. Drugs (1985) 1.07
Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin. Scand J Infect Dis (1992) 1.06
Perceived symptoms amongst hypertensive patients in routine clinical practice- a population-based study. J Intern Med (1998) 1.03
Ambulatory blood pressure 16-26 years after the first urinary tract infection in childhood. J Hypertens (2000) 1.02
Ketanserin in essential hypertension: effects during rest and exercise. Eur J Clin Pharmacol (1983) 1.02
Morbidity in representative male survivors of myocardial infarction compared to representative population samples. J Chronic Dis (1976) 1.01
Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. J Neural Transm (1985) 1.01
Deaths and non-fatal reinfarctions during two years' follow-up after myocardial infarction. Acta Med Scand (1975) 1.00
Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand (1998) 1.00
Atrial peptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population. Eur Heart J (1993) 0.99
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension (1998) 0.99
Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction. Heart Lung (1997) 0.99
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res (1999) 0.98
Lowered blood pressure and the J-shaped curve. Lancet (1987) 0.98
The Multifactor Primary Prevention Trial in Göteborg, Sweden. Comparison with a previously untreated population sample. Drugs (1986) 0.97
Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension. Br J Clin Pharmacol (1984) 0.97
Regulation of breathing in the rat: indications for a role of central adenosine mechanisms. Neurosci Lett (1982) 0.97
Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. Maturitas (1994) 0.97
Intraarticular morphine after arthroscopic ACL reconstruction: a double-blind placebo-controlled study of 40 patients. Acta Orthop Scand (2000) 0.96
Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. Life Sci (1999) 0.96
Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden. J Hypertens (1985) 0.95
Characteristics of representative male survivors of myocardial infarction compared with representative population samples. Acta Med Scand (1976) 0.95
Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain. Br J Clin Pharmacol (2005) 0.95
Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol (1994) 0.95
Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.94
Pressure-volume relationship and fluid content in fetal rabbit lung after beta-receptor-stimulating drugs. Pediatr Res (1980) 0.94
Renal and hemodynamic effects of isradipine in essential hypertension. Am J Med (1989) 0.94
The neuropharmacology of respiratory control. Pharmacol Rev (1982) 0.93